Affimed (AFMD) Misses Q3 EPS by 9c

Affimed (NASDAQ: AFMD) reported Q3 EPS of (EUR0.94), EUR0.09 worse than the analyst estimate of (EUR0.85). Revenue for the quarter came in at EUR150 thousand versus the consensus estimate of EUR1.42 million.

For earnings history and earnings-related data on Affimed (AFMD) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Tractor Supply Company (TSCO) PT Lowered to $33 at Gordon Haskett
• Bernstein SocGen on GE Aerospace (GE): 'Expect upside to guidance as fuel price pressure moderates'